131 related articles for article (PubMed ID: 16889192)
21. Furosemide in postpartum management of severe preeclampsia: A randomized controlled trial.
Veena P; Perivela L; Raghavan SS
Hypertens Pregnancy; 2017 Feb; 36(1):84-89. PubMed ID: 27835048
[TBL] [Abstract][Full Text] [Related]
22. [Effect of the blood pressure on the perinatal fetal outcome in patients with preeclampsia].
Ivanov S; Stoĭkova V; Mikhova M; Sigridov I; Batashki I
Akush Ginekol (Sofiia); 2006; 45(1):3-7. PubMed ID: 16637309
[TBL] [Abstract][Full Text] [Related]
23. Discontinuation of antihypertensive drug use during the first trimester of pregnancy and the risk of preeclampsia and eclampsia among women with chronic hypertension.
Nakhai-Pour HR; Rey E; Bérard A
Am J Obstet Gynecol; 2009 Aug; 201(2):180.e1-8. PubMed ID: 19646568
[TBL] [Abstract][Full Text] [Related]
24. [Management of severe pre-eclampsia in the puerperium. Comparative study of sublingual nifedipine and hydralazine].
Walss Rodríguez RJ; Villarreal Ordaz F
Ginecol Obstet Mex; 1991 Jul; 59():207-10. PubMed ID: 1769603
[TBL] [Abstract][Full Text] [Related]
25. A prospective randomized trial of magnesium sulfate in severe preeclampsia: use of diuresis as a clinical parameter to determine the duration of postpartum therapy.
Fontenot MT; Lewis DF; Frederick JB; Wang Y; DeFranco EA; Groome LJ; Evans AT
Am J Obstet Gynecol; 2005 Jun; 192(6):1788-93; discussion 1793-4. PubMed ID: 15970809
[TBL] [Abstract][Full Text] [Related]
26. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
[TBL] [Abstract][Full Text] [Related]
27. Arterial stiffness and dipper/nondipper blood pressure status in women with preeclampsia.
Arioz DT; Saglam H; Demirel R; Koken G; Cosar E; Sahin FK; Dursun H; Aral I; Onrat E; Yilmazer M
Adv Ther; 2008 Sep; 25(9):925-34. PubMed ID: 18758697
[TBL] [Abstract][Full Text] [Related]
28. Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension.
Mistry GC; Maes AL; Lasseter KC; Davies MJ; Gottesdiener KM; Wagner JA; Herman GA
J Clin Pharmacol; 2008 May; 48(5):592-8. PubMed ID: 18353996
[TBL] [Abstract][Full Text] [Related]
29. ACE inhibitor-based treatment and antihypertensive effects in patients with type 2 diabetes.
Jarmuzewska EA; Rocchi R; Guidoni A; Mangoni AA
Panminerva Med; 2008 Sep; 50(3):207-16. PubMed ID: 18927524
[TBL] [Abstract][Full Text] [Related]
30. Good blood pressure control on antihypertensives, not only response to spironolactone, predicts improved outcome after adrenalectomy for aldosteronoma.
Zarnegar R; Lee J; Brunaud L; Lindsay S; Kebebew E; Clark OH; Duh QY
Surgery; 2007 Dec; 142(6):921-9; discussion 921-9. PubMed ID: 18063077
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
Kim SH; Chung WY; Zo JH; Kim MA; Chang HJ; Cho YS; Youn TJ; Chae IH; Choi DJ; Gwak JJ; Lee HY; Park JS; Kang HJ; Kim YJ; Kim HS
Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099
[TBL] [Abstract][Full Text] [Related]
32. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
Tytus RH; Burgess ED; Assouline L; Vanjaka A
Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
[TBL] [Abstract][Full Text] [Related]
33. [Hypotensive effect of 6-months cardiac rehabilitation in elderly patients].
Kałka D; Sobieszczańska M; Marciniak W; Chorebała A; Markuszewski L; Metner E; Popielewicz-Kautz A; Korzeniowska J; Janczak J; Adamus J
Pol Merkur Lekarski; 2007 Feb; 22(128):95-100. PubMed ID: 17598651
[TBL] [Abstract][Full Text] [Related]
34. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
Saito I; Saruta T;
Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
[TBL] [Abstract][Full Text] [Related]
35. Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring.
Karotsis AK; Symeonidis A; Mastorantonakis SE; Stergiou GS;
Clin Exp Hypertens; 2006 Oct; 28(7):655-62. PubMed ID: 17060064
[TBL] [Abstract][Full Text] [Related]
36. Antenatal risk factors associated with need of postpartum antihypertensives in women with preeclampsia in South India: Case control study.
Keepanasseril A; Yadav BK; Maurya DK
Pregnancy Hypertens; 2017 Apr; 8():42-45. PubMed ID: 28501278
[TBL] [Abstract][Full Text] [Related]
37. Beneficial effects of metolazone in a rat model of preeclampsia.
Pridjian G; Pridjian C; Danchuk S; Ianosi-Irimie M; Vu HV; Puschett JB
J Pharmacol Exp Ther; 2006 Sep; 318(3):1027-32. PubMed ID: 16717105
[TBL] [Abstract][Full Text] [Related]
38. Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease.
Ho PM; Magid DJ; Shetterly SM; Olson KL; Peterson PN; Masoudi FA; Rumsfeld JS
Arch Intern Med; 2008 Feb; 168(3):271-6. PubMed ID: 18268167
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for postpartum antihypertensive medication requirement in severe preeclampsia.
Peterson E; Craigo S; House M
Hypertens Pregnancy; 2010; 29(3):350-6. PubMed ID: 20670157
[TBL] [Abstract][Full Text] [Related]
40. [Effect of Urapidil in antihypertensive therapy of preeclampsia on newborns].
Schulz M; Wacker J; Bastert G
Zentralbl Gynakol; 2001 Sep; 123(9):529-33. PubMed ID: 11709746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
